Wall Street brokerages expect that Natus Medical Incorporated (NASDAQ:BABY) will post $0.38 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Natus Medical’s earnings. The lowest EPS estimate is $0.37 and the highest is $0.38. Natus Medical reported earnings of $0.39 per share in the same quarter last year, which would suggest a negative year over year growth rate of 2.6%. The firm is expected to report its next earnings report on Wednesday, October 18th.

On average, analysts expect that Natus Medical will report full-year earnings of $1.70 per share for the current year. For the next financial year, analysts forecast that the business will post earnings of $1.98 per share, with EPS estimates ranging from $1.90 to $2.05. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Natus Medical.

Natus Medical (NASDAQ:BABY) last announced its quarterly earnings results on Wednesday, July 26th. The medical equipment provider reported $0.34 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.33 by $0.01. Natus Medical had a return on equity of 12.09% and a net margin of 4.20%. The firm had revenue of $122.20 million during the quarter, compared to analyst estimates of $121.99 million. During the same quarter in the previous year, the business earned $0.39 EPS. Natus Medical’s revenue for the quarter was up 27.3% compared to the same quarter last year.

Several research analysts recently issued reports on the stock. BidaskClub cut shares of Natus Medical from a “sell” rating to a “strong sell” rating in a report on Thursday, August 24th. Zacks Investment Research cut shares of Natus Medical from a “hold” rating to a “sell” rating in a report on Friday, July 28th. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $44.50.

Shares of Natus Medical (BABY) opened at 35.10 on Friday. The firm has a market capitalization of $1.14 billion, a PE ratio of 60.83 and a beta of 0.96. The company has a 50-day moving average price of $33.95 and a 200 day moving average price of $36.10. Natus Medical has a 12-month low of $31.65 and a 12-month high of $44.39.

In other Natus Medical news, Director Robert A. Gunst sold 4,400 shares of the stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $35.17, for a total value of $154,748.00. Following the completion of the transaction, the director now directly owns 50,850 shares of the company’s stock, valued at $1,788,394.50. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director William M. Moore sold 3,000 shares of the stock in a transaction dated Monday, August 14th. The shares were sold at an average price of $34.10, for a total transaction of $102,300.00. Following the completion of the transaction, the director now directly owns 30,410 shares of the company’s stock, valued at $1,036,981. The disclosure for this sale can be found here. Company insiders own 5.50% of the company’s stock.

A number of institutional investors have recently modified their holdings of BABY. BlackRock Inc. increased its holdings in Natus Medical by 137,510.8% in the first quarter. BlackRock Inc. now owns 4,124,195 shares of the medical equipment provider’s stock valued at $161,874,000 after buying an additional 4,121,198 shares in the last quarter. Columbia Wanger Asset Management LLC increased its holdings in Natus Medical by 243.6% in the first quarter. Columbia Wanger Asset Management LLC now owns 2,030,207 shares of the medical equipment provider’s stock valued at $79,686,000 after buying an additional 1,439,382 shares in the last quarter. Wellington Management Group LLP increased its holdings in Natus Medical by 105.7% in the first quarter. Wellington Management Group LLP now owns 1,795,094 shares of the medical equipment provider’s stock valued at $70,457,000 after buying an additional 922,268 shares in the last quarter. Koch Industries Inc. increased its holdings in Natus Medical by 7,423.5% in the second quarter. Koch Industries Inc. now owns 462,472 shares of the medical equipment provider’s stock valued at $450,000 after buying an additional 456,325 shares in the last quarter. Finally, Epoch Investment Partners Inc. increased its holdings in Natus Medical by 68.3% in the first quarter. Epoch Investment Partners Inc. now owns 1,110,932 shares of the medical equipment provider’s stock valued at $43,604,000 after buying an additional 450,698 shares in the last quarter. 92.65% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Natus Medical Incorporated (BABY) Expected to Announce Earnings of $0.38 Per Share” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another site, it was stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this news story can be read at https://www.americanbankingnews.com/2017/09/16/natus-medical-incorporated-baby-expected-to-announce-earnings-of-0-38-per-share.html.

Natus Medical Company Profile

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.

Get a free copy of the Zacks research report on Natus Medical (BABY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Natus Medical (NASDAQ:BABY)

Receive News & Ratings for Natus Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.